1888PressRelease.com
1888 PressRelease Home Sign In Register About Us Sitemap
27
Apr
2009

BITS Pilani Research Gears to Roll Back Malaria out of India Today

Malaria is caused by a parasite called Plasmodium, which is transmitted via the bites of infected mosquitoes. In the human body, the parasites multiply in the liver. If not treated, malaria can quickly become life-threatening by disrupting the blood supply to vital organs. In many parts of the world, the parasites have developed resistance to a number of malaria medicines.


(1888PressRelease) April 27, 2009 - A child dies of malaria every 30 seconds and malaria takes an economic toll - cutting economic growth rates by as much as 1.3% in countries with high disease rates.

Key interventions to control malaria include - prompt and effective treatment with artemisinin-based combination therapies; use of insecticidal nets by people at risk; and indoor residual spraying with insecticide to control the vector mosquitoes.

World Malaria Day observed on April 25th represents a chance for everyone to make a difference to roll back malaria and help generate broad gains in multiple areas of health and human development. Reducing the impact of malaria would significantly propel efforts to achieve the Millennium Development Goals as agreed by every United Nations member state. World Malaria Day is more than a commemoration - it is a time to rally our forces to stop this disease says UN Secretary-General Ban Ki-moon.

Recently the National Assessment and Accreditation Council NAAC reaccredited Birla Institute of Technology & Science popularly known as BITS Pilani with 3.71 CGPA out of 4 and awarded “A” grade “Very Good” status.

Prof AK Das (Email: adas(at)bits-pilani.ac.in) Group Leader Biological Sciences at BITS Pilani is spearheading a project on Systems Biology approach towards understanding severe malaria with special reference to the transcriptome and proteome of the parasite and the host.

Dr Das obtained his Masters from Ballygunj Science College, Kolkata, and PhD from National Institute of Immunology New Delhi, India. His experience includes Working as Post Doctoral Fellow in the Department of Molecular Biology and Immunology, SHPH, Johns Hopkins University, Baltimore, USA and as WHO Fellow at the Malaria Branch, Center for Disease Control, Atlanta, Georgia USA.

Research interests of Dr Das include Molecular and Immuno - Parasitology, Molecular Diagnostics and industrially oriented projects dealing with different aspects of vector design, cloning and expression and bioinformatics. One of the major thrust areas of the Biological Sciences Group is research into Molecular Biology and Immunology of the human malarial parasites.

Presently research is focused on investigating polymorphisms in major candidate vaccine antigens like MSP1 and AMA1, which could have implications in vaccine design. They are also investigating the Apicoplast of P. vivax from Indian isolates and have initiated preliminary experiments investigating prevalence of putative Drug Resistance markers.

Another facet of the research work deals with formulating diagnostic procedures for the human malarial parasites based on the parasite 18s rRNA and 28s rRNA/ rRNA gene. Investigations are also focused on a novel phenomenon of cerebral malaria caused by P. vivax. A dedicated team of researchers are involved in industry related projects involving prokaryotic vector design and expression of cytokines.

For Dr AK Das of BITS Pilani, Research is indeed a Mission with Passion.

###
 

Other Related Press Releases

Sorenson's Ranch School - 50 Years Of Successful Experience In Adolescent Treatment Of Reactive Attachment Disorder For Troubled Teens by Sorensons Ranch School

BITS Pilani Research Gears to Roll Back Malaria out of India Today by Br Natarajan

Vibration-free Co-extrusion With Flexible Heating Hoses by Strictly Extrusion

Infosim Announces StableNet Telco 5.0; Extends Management For Carrier Ethernet And Deep-fibre Services by Infosim/press

Contact Information

BR NATARAJAN

Br Natarajan

333031

Voice: 91-1596-242210

Visit our Site

Press Release Tools